Enterogenic Intensive I00 By Integrative Therapeutics Overview & Drug Interactions
Check For Interactions With Enterogenic Intensive I00
Supplement: Enterogenic Intensive I00 by Integrative Therapeutics
Enterogenic Intensive I00 Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Total Carbohydrates
| Ingredient Group | Carbohydrate |
|---|---|
| Category | sugar |
Proprietary Probiotic Blend
| Ingredient Group | Proprietary Blend (non-nutrient/non-botanical) |
|---|---|
| Category | blend |
Lactobacilli
| Ingredient Group | Lactobacillus (unspecified) |
|---|---|
| Category | bacteria |
-
L. casei HA-108
Ingredient Group Lactobacillus casei Category bacteria
L. Paracasei HA-274
Ingredient Group Lactobacillus paracasei Category bacteria
L. acidophilus HA-122
Description:Lactobacillus acidophilus is a type of lactic acid-producing bacteria that is commonly found in the human gut, as well as in other areas of the body such as the mouth and vagina. L. acidophilus can also be found in fermented foods such as yogurt and kefir. It is commonly utilized in probiotic dietary supplements as it is considered a "friendly" or "beneficial" bacteria because it helps to maintain the balance of microorganisms in the body, and is purported to help improve digestion and boost the immune system. Some studies have suggested that L. acidophilus may also have a role in preventing and treating certain conditions such as diarrhea, vaginal yeast infections, and eczema.
See More Information Regarding Lactobacillus Acidophilus
Ingredient Group Lactobacillus acidophilus Category bacteria
L. rhamnosus HA-111
Ingredient Group Lactobacillus rhamnosus Category bacteria
L. rhamnosus HA-114
Ingredient Group Lactobacillus rhamnosus Category bacteria
L. salivarius HA-118
Ingredient Group Lactobacillus salivarius Category bacteria
Bifidobacteria
| Ingredient Group | Bifidobacterium (unspecified) |
|---|---|
| Category | bacteria |
-
B. breve HA-129
Ingredient Group Brevibacillus Category bacteria
B. bifidum HA-132
Ingredient Group Bifidobacterium bifidum Category bacteria
B. longum HA-135
Ingredient Group Bifidobacterium longum Category bacteria
B. infantis HA-116
Ingredient Group Bifidobacterium infantis Category bacteria
NutraFlora
| Ingredient Group | Fructo-Oligosaccharides (FOS) |
|---|---|
| Category | fiber |
- Fructooligosaccharides
Drugs that interact with Enterogenic Intensive I00 by Integrative Therapeutics
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Capsule(s)
|
| Maximum serving Sizes: |
1 Capsule(s)
|
| UPC/BARCODE | 871791706675 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Total Carbohydrates |
1 Gram(s)
|
Carbohydrate |
1%
|
| Proprietary Probiotic Blend |
479 mg
|
Proprietary Blend (non-nutrient/non-botanical) |
--
|
| Lactobacilli |
0 NP
|
Lactobacillus (unspecified) |
|
| L. casei HA-108 |
0 NP
|
Lactobacillus casei |
|
| L. Paracasei HA-274 |
0 NP
|
Lactobacillus paracasei |
|
| L. acidophilus HA-122 |
0 NP
|
Lactobacillus acidophilus |
|
| L. rhamnosus HA-111 |
0 NP
|
Lactobacillus rhamnosus |
|
| L. rhamnosus HA-114 |
0 NP
|
Lactobacillus rhamnosus |
|
| L. salivarius HA-118 |
0 NP
|
Lactobacillus salivarius |
|
| Bifidobacteria |
0 NP
|
Bifidobacterium (unspecified) |
|
| B. breve HA-129 |
0 NP
|
Brevibacillus |
|
| B. bifidum HA-132 |
0 NP
|
Bifidobacterium bifidum |
|
| B. longum HA-135 |
0 NP
|
Bifidobacterium longum |
|
| B. infantis HA-116 |
0 NP
|
Bifidobacterium infantis |
|
| NutraFlora |
75 mg
|
Fructo-Oligosaccharides (FOS) |
--
|
| Other Ingredients: |
Hydroxypropyl Methylcellulose
Potato Starch
Hydroxypropyl Methylcellulose
Magnesium Stearate
Ethylcellulose
Sodium Alginate
Silicon Dioxide
Medium-Chain Triglycerides
Ascorbic Acid
Oleic Acid
Stearic Acid
|
|---|
Label Statments:
| General Statements |
- Form more information, please visit integrativepro.com
- Probiotics
|
|---|---|
| Precautions |
- If pregnant, nursing or taking prescription drugs, consult your healthcare professional prior to use.
- Contains: milk and soy
|
| Brand IP Statement(s) |
- NutraFlora and scFOS are registered trademarks of GTC nutrition.
|
| Formulation |
- Contains no wheat, gluten, corn, artificial colors, flavors or preservatives.
|
| General |
- LZ70667.A02 B712400A
|
| FDA Statement of Identity |
- Dietary Supplement
|
| Formula |
- Contains: milk and soy
|
| Suggested/Recommended/Usage/Directions |
- Recommendations: Take 1 capsule daily. May be taken at any time, with or without food, or as recommended by your healthcare professional. Keep refrigerated to maintain maximum potency. 100 billion CFU potency per capsule is guaranteed until expiration date when bottle is kept tightly closed and refrigerated.
|
| FDA Disclaimer Statement |
- This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
Brand Information
See all products by this brand
| Distributed by | |
|---|---|
| Name | Integrative Therapeutics, LLC |
| City | Green Bay |
| State | WI |
| Country | USA |
| ZipCode | 54311 |
| Phone Number | 800.931.1709 |
| Web Address | integrativepro.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.